Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-02-21

FDA Approved: CARDENE IV — Supplemental Application (Baxter Healthcare Corporation)

View source ↗

Summary

The FDA approved a supplemental application for Cardene IV (nicardipine hydrochloride) from Baxter Healthcare Corporation, confirming the intravenous formulatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARDENE IV (nicardipine hydrochloride)

Snippet

SUPPL AP for CARDENE IV (NICARDIPINE HYDROCHLORIDE)